Marc Casper, Thermo Fisher CEO (Suzanne Kreiter/The Boston Globe via Getty Images)

October 31, 2022 11:10 AM EDT

Thermo Fisher wagers on early cancer diagnostics in $2.6B cash deal for multiple myeloma test maker

Always on the lookout for the next thing to buy, Thermo Fisher Scientific has settled on an oncology diagnostic player for its latest acquisition. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ther­mo Fish­er wa­gers on ear­ly can­cer di­ag­nos­tics in $2.6B cash deal for mul­ti­ple myelo­ma test mak­er